查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1790365

美國抗生物膜傷口敷料市場規模、佔有率和趨勢分析報告：按機制、應用、最終用途、地區和細分市場預測，2025-2030 年

U.S. Anti-biofilm Wound Dressing Market Size, Share & Trends Analysis Report By Mode of Mechanism (Physical, Chemical, Biological), By Application (Chronic Wounds, Acute Wounds), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

美國抗生物膜傷口敷料市場概況

2024 年美國抗生物膜傷口敷料市場規模為 3.142 億美元，預計到 2030 年將達到 5.463 億美元，2025 年至 2030 年的複合年成長率為 9.8%。市場成長歸因於糖尿病、癌症、心血管疾病和其他自體免疫疾病等慢性疾病的增加導致慢性和急性傷口的盛行率不斷上升。

根據美國疾病管制與預防中心的數據，截至 2021 年，超過 3,800 萬人（占美國總人口的 11% 以上）患有糖尿病。美國道路交通事故數量的增加極大地促進了市場的成長。根據美國運輸部的數據，到 2024 年，將有超過 39,000 人死於道路交通事故。道路交通事故的增加推動了對具有抗生物膜特性的創傷護理產品的需求，因為這些事故可能導致嚴重燒燙傷和創傷。政府和私人部門不斷增加對先進創傷護理技術的投資，以改善患者治療效果並降低醫療保健成本，這進一步促進了市場的成長。

法律規範確保安全性和有效性，促進先進抗菌敷料的採用，而最終用途集中凸顯了醫院、專科診所和門診診所等關鍵醫療保健部門對推動需求的重要性。

創新依然至關重要，因為各公司都在大力投入研發，以開發具有增強抗生物膜功能的敷料。 2025年4月，康維泰克宣布計劃首次推出其新技術ConvaNiox，利用強效抗菌和抗生物膜劑一氧化氮。 ConvaNiox最初將用於治療糖尿病足潰瘍 (DFU)，並已被證明與標準治療相比，其傷口面積減少速度加快三倍，DFU癒合率提高60%。

糖尿病盛行率的上升，加上人口老化，進一步推動了需求成長。製造商紛紛提高產量，拓展產品線，以滿足此細分市場的獨特需求。例如，許多公司正在擴大其在美國的生產能力，並加強分銷網路，以便更好地服務醫療保健機構。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國抗生物膜傷口敷料市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關市場展望
  • 產業價值鏈分析
  • 法律規範
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 產業挑戰
    • 行業機會
  • 產業分析工具
    • 波特五力分析

第4章美國抗生物膜傷口敷料市場：機制、估算與趨勢分析

  • 細分儀表板
  • 美國抗生物膜傷口敷料市場：機制變異分析和市場佔有率（2024 年和 2030 年）
  • 身體的
    • 手動清創
    • 脈衝電場
    • 超音波清創
  • 化學品
    • 離子銀
    • 碘
    • EDTA
    • 其他
  • 生物
    • 分散素B
    • 乳鐵蛋白
    • 噬菌體
    • 其他

第5章美國抗生物膜傷口敷料市場：應用、預測與趨勢分析

  • 細分儀表板
  • 美國抗生物膜傷口敷料市場：應用變化分析和市場佔有率（2024 年和 2030 年）
  • 慢性傷口
    • 糖尿病足潰瘍
    • 壓瘡
    • 靜脈性腿部潰瘍
    • 其他
  • 急性傷口
    • 外科性創傷與創傷傷口
    • 燒燙傷

第6章。美國抗生物膜傷口敷料市場（按最終用途、估計和趨勢分析）

  • 細分儀表板
  • 美國抗生物膜傷口敷料市場：2024 年和 2030 年最終用途變化分析和市場佔有率
  • 醫院
  • 專科診所
  • 家庭醫療保健
  • 其他

第7章美國抗生物膜傷口敷料市場競爭格局

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司分類
  • 公司熱圖
  • 2024年排名分析
  • 戰略地圖
    • 擴張
    • 合併與收購
    • 夥伴關係和合作
    • 新產品發布
    • 研究與開發
  • 公司簡介
    • ConvaTec Inc.
    • Smith & Nephew PLC
    • Imbed Biosciences
    • Next Science
    • B. Braun Melsungen AG
    • 3M
    • Molnlycke Health Care AB
    • Coloplast
    • Lohmann & Rauscher
Product Code: GVR-4-68040-666-0

U.S. Anti-Biofilm Wound Dressing Market Summary

The U.S. anti-biofilm wound dressing market size was valued at USD 314.2 million in 2024 and is projected to reach USD 546.3 million by 2030, growing at a CAGR of 9.8% from 2025 to 2030. The market's growth can be attributed to the growing prevalence of chronic and acute wounds owing to the increase in chronic diseases, including diabetes, cancer, cardiovascular diseases, and other autoimmune diseases.

According to the U.S. Centers for Disease Control and Prevention, as of 2021, over 38 million people, over 11% of the overall U.S. population, had diabetes. The country's increasing number of road accidents significantly contributes to the market's growth. According to the U.S. Department of Transportation's National Highway Traffic Safety Administration, over 39,000 people died in road accidents in 2024. The growing number of road accidents increases the demand for wound care products with anti-biofilm properties, as these accidents can lead to severe burns and traumatic injuries. The increasing government and private investments in advanced wound care technologies to improve patient outcomes and lower healthcare costs further contribute to the market's growth.

Regulatory frameworks ensure safety and efficacy and promote the adoption of advanced antimicrobial dressings, while end-use concentration highlights the significance of key healthcare segments such as hospitals, specialty clinics, and outpatient clinics in driving demand.

Innovation remains crucial as companies invest heavily in R&D to develop dressings with enhanced anti-biofilm capabilities. In April 2025, Convatec announced its plans for the initial market launch of ConvaNiox, a new technology powered by a potent antimicrobial and antibiofilm agent, nitric oxide, which is supported by strong clinical evidence. ConvaNiox will be initially used for the management of diabetic foot ulcers (DFUs), which has been demonstrated to reduce the wound area three times faster and increase DFU healing by 60% in comparison to the standard of care.

The rising incidence of diabetes, alongside an aging demographic, further increases the demand, urging manufacturers to increase production and broaden their product ranges to cater to the sector's specific requirements. For instance, numerous companies have enhanced their manufacturing capabilities within the U. S. and fortified their distribution networks to serve healthcare providers better.

U.S. Anti-biofilm Wound Dressing Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. anti-biofilm wound dressing market report based on mode of mechanism, application, and end-use:

  • Mode of Mechanism (Revenue, USD Million, 2018 - 2030)
  • Physical
    • Manual Debridement
    • Pulse Electrical Field
    • Ultrasound Debridement
  • Chemical
    • Ionic Silver
    • Iodine
    • EDTA
    • Others
  • Biological
    • Dispersin B
    • Lactoferrin
    • Bacteriophage
    • Others
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Chronic Wounds
    • Diabetic Foot Ulcers
    • Pressure Ulcers
    • Venous Leg Ulcers
    • Others
  • Acute Wounds
    • Surgical & Traumatic Wounds
    • Burn Wounds
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Specialty Clinics
  • Home Healthcare
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Anti-biofilm Wound Dressing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related Market Outlook
  • 3.2. Industry Value Chain Analysis
  • 3.3. Regulatory Framework
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
    • 3.4.3. Industry Challenges
    • 3.4.4. Industry Opportunities
  • 3.5. Industry Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis

Chapter 4. U.S. Anti-biofilm Wound Dressing Market: Mode of Mechanism Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Anti-biofilm Wound Dressing Market: Mode of Mechanism Movement Analysis & Market Share, 2024 & 2030
  • 4.3. Physical
    • 4.3.1. Physical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Manual Debridement
      • 4.3.2.1. Manual Debridement Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Pulse Electrical Field
      • 4.3.3.1. Pulse Electrical Field Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Ultrasound Debridement
      • 4.3.4.1. Ultrasound Debridement Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Chemical
    • 4.4.1. Chemical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Ionic Silver
      • 4.4.2.1. Ionic Silver Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Iodine
      • 4.4.3.1. Iodine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. EDTA
      • 4.4.4.1. EDTA Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Biological
    • 4.5.1. Biological Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Dispersin B
      • 4.5.2.1. Disperin B Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Lactoferrin
      • 4.5.3.1. Lactoferrin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Bacteriophage
      • 4.5.4.1. Bacteriophage Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Anti-biofilm Wound Dressing Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Anti-biofilm Wound Dressing Market: Application Movement Analysis & Market Share, 2024 & 2030
  • 5.3. Chronic Wounds
    • 5.3.1. Chronic Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Diabetic Foot Ulcers
      • 5.3.2.1. Diabetic Foot Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Pressure Ulcers
      • 5.3.3.1. Pressure Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Venous Leg Ulcers
      • 5.3.4.1. Venous Leg Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.5. Others
      • 5.3.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Acute Wounds
    • 5.4.1. Acute Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Surgical & Traumatic Wounds
      • 5.4.2.1. Surgical & Traumatic Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Burn Wounds
      • 5.4.3.1. Burn Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Anti-biofilm Wound Dressing Market: End-Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Anti-biofilm Wound Dressing Market: End-Use Movement Analysis & Market Share, 2024 & 2030
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Specialty Clinics
    • 6.4.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Home Healthcare
    • 6.5.1. Specialty Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Anti-biofilm Wound Dressing Market - Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map
  • 7.4. Position Analysis, 2024
  • 7.5. Strategy Mapping
    • 7.5.1. Expansion
    • 7.5.2. Mergers & Acquisition
    • 7.5.3. Partnerships & Collaborations
    • 7.5.4. New Product Launches
    • 7.5.5. Research and Development
  • 7.6. Company Profiles
    • 7.6.1. ConvaTec Inc.
      • 7.6.1.1. Participant's overview
      • 7.6.1.2. Financial performance
      • 7.6.1.3. Product benchmarking
      • 7.6.1.4. Recent developments
    • 7.6.2. Smith & Nephew PLC
      • 7.6.2.1. Participant's overview
      • 7.6.2.2. Financial performance
      • 7.6.2.3. Product benchmarking
      • 7.6.2.4. Recent developments
    • 7.6.3. Imbed Biosciences
      • 7.6.3.1. Participant's overview
      • 7.6.3.2. Financial performance
      • 7.6.3.3. Product benchmarking
      • 7.6.3.4. Recent developments
    • 7.6.4. Next Science
      • 7.6.4.1. Participant's overview
      • 7.6.4.2. Financial performance
      • 7.6.4.3. Product benchmarking
      • 7.6.4.4. Recent developments
    • 7.6.5. B. Braun Melsungen AG
      • 7.6.5.1. Participant's overview
      • 7.6.5.2. Financial performance
      • 7.6.5.3. Product benchmarking
      • 7.6.5.4. Recent developments
    • 7.6.6. 3M
      • 7.6.6.1. Participant's overview
      • 7.6.6.2. Financial performance
      • 7.6.6.3. Product benchmarking
      • 7.6.6.4. Recent developments
    • 7.6.7. Molnlycke Health Care AB
      • 7.6.7.1. Participant's overview
      • 7.6.7.2. Financial performance
      • 7.6.7.3. Product benchmarking
      • 7.6.7.4. Recent developments
    • 7.6.8. Coloplast
      • 7.6.8.1. Participant's overview
      • 7.6.8.2. Financial performance
      • 7.6.8.3. Product benchmarking
      • 7.6.8.4. Recent developments
    • 7.6.9. Lohmann & Rauscher
      • 7.6.9.1. Participant's overview
      • 7.6.9.2. Financial performance
      • 7.6.9.3. Product benchmarking
      • 7.6.9.4. Recent developments

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. anti-biofilm wound dressing market 2018 - 2030 (USD Million)
  • Table 3 U.S. anti-biofilm wound dressing market estimates and forecasts by mode of mechanism 2018 - 2030 (USD Million)
  • Table 4 U.S. anti-biofilm wound dressing market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • Table 5 U.S. anti-biofilm wound dressing market estimates and forecasts by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 QFD Modeling for Market Share Assessment
  • Fig. 6 Information Procurement
  • Fig. 7 Market Formulation and Validation
  • Fig. 8 Data Validating & Publishing
  • Fig. 9 Market Segmentation & Scope
  • Fig. 10 U.S. Anti-biofilm Wound Dressing Market Snapshot
  • Fig. 11 Segment Snapshot (1/2)
  • Fig. 12 Segment Snapshot (1/2)
  • Fig. 13 Competitive Landscape Snapshot
  • Fig. 14 Parent market outlook
  • Fig. 15 U.S. Anti-biofilm Wound Dressing Market Value, 2024 (USD Million)
  • Fig. 16 U.S. Anti-biofilm Wound Dressing Market - Value Chain Analysis
  • Fig. 17 U.S. Anti-biofilm Wound Dressing Market - Market Dynamics
  • Fig. 18 U.S. Anti-biofilm Wound Dressing Market - PORTER's Analysis
  • Fig. 19 U.S. Anti-biofilm Wound Dressing Market - PESTEL Analysis
  • Fig. 20 U.S. Anti-biofilm Wound Dressing Market Estimates & Forecasts, by Mode of Mechanism: Key Takeaways
  • Fig. 21 U.S. Anti-biofilm Wound Dressing Market Share, by Mode of Mechanism, 2024 & 2030
  • Fig. 22 Physical Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Manual Debridement Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Pulse Electrical Field Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Ultrasound Debridement Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Chemical Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Ionic Silver Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Iodine Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 EDTA Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Others Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Biological Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Dispersin B Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Lactoferrin Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Bacteriophage Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Others Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. Anti-biofilm Wound Dressing Market Estimates & Forecasts, by Application: Key Takeaways
  • Fig. 37 Chronic Wounds Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Diabetic Foot Ulcers Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Pressure Ulcers Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Venous Leg Ulcers Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Others Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Acute Wounds Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Surgical & Traumatic Wounds Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Burn Wounds Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 U.S. Anti-biofilm Wound Dressing Market Estimates & Forecasts, by End-Use: Key Takeaways
  • Fig. 46 Hospitals Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Specialty Clinics Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Home Healthcare Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Others Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key Company Categorization
  • Fig. 51 Company Market Positioning
  • Fig. 52 Strategy Mapping